Ownership
Private
Employees
~50
Stage
Preclinical
Modalities
Small molecule

Quris AI General Information

Developing AI-based platform to predict drug safety and efficacy before human clinical trials, preparing for clinical testing with first AI-based drug

Contact Information

Website
Primary Industry
CRO
Corporate Office
Boston, Massachusetts
United States

Drug Pipeline

No pipeline data available

For full access to Quris AI's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Quris AI Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Quris AI's complete valuation and funding history, request access »

Quris AI Investors

iAngels
Investor Type: Venture Capital
Holding: Minority
strategic biotech investors
Investor Type: Venture Capital
Holding: Minority
big data investors
Investor Type: Venture Capital
Holding: Minority